LHM Inc. decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 29.9% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 83,738 shares of the exchange traded fund’s stock after selling 35,802 shares during the period. SPDR S&P Biotech ETF accounts for about 3.8% of LHM Inc.’s holdings, making the stock its 5th largest position. LHM Inc. owned about 0.13% of SPDR S&P Biotech ETF worth $10,210,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Legacy Wealth Managment LLC ID bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter valued at approximately $32,000. Ballast Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 4th quarter worth $36,000. Creative Financial Designs Inc. ADV acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $39,000. Barnes Dennig Private Wealth Management LLC bought a new stake in SPDR S&P Biotech ETF during the fourth quarter valued at about $48,000. Finally, Navalign LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth about $48,000.
SPDR S&P Biotech ETF Stock Performance
NYSEARCA XBI opened at $135.99 on Friday. The stock has a 50-day simple moving average of $130.68 and a 200 day simple moving average of $125.86. SPDR S&P Biotech ETF has a twelve month low of $78.06 and a twelve month high of $139.19. The stock has a market capitalization of $8.68 billion, a PE ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
See Also
- Five stocks we like better than SPDR S&P Biotech ETF
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
